Efficacy, Safety and Costs of Methotrexate, Adalimumab, or Their Combination in Non-infectious Non-anterior Uveitis

NCT04798755 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

192

Enrollment

OTHER

Sponsor class

Conditions

Uveitis

Interventions

DRUG: Methotrexate
DRUG: Adalimumab
DRUG: Adalimumab+Methotrexate

Sponsor

Hospital San Carlos, Madrid